Conversely, the authors showed that NF-κB inhibition ameliorates sepsis-induced AKI in the CLP model, which is in agreement with our finding that pre-CLP administration of CERA maintained normal expression of AQP2 and NKCC2. Here, NFKB1 is linked to acute kidney injury.